Williamson, Andrew J. K.

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells

Abraham, S. A., Hopcroft, L. E. M., Carrick, E., Drotar, M. E., Dunn, K., Williamson, A. J. K., Korfi, K., Baquero, P., Park, L. E., Scott, M. T., et al. (2016) · Nature

Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

Cited by 225

Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program

Hoogenkamp, M., Lichtinger, M., Krysinska, H., Lancrin, C., Clarke, D., Williamson, A., Mazzarella, L., Ingram, R., Jorgensen, H., Fisher, A., et al. (2009) · Blood

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 121

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., et al. (2020) · Leukemia

Acute Myeloid Leukemia ResearchS100 Proteins and Annexins

Cited by 64